Capsida Biotherapeutics Surplus Sale Features Chromatography, Automation and Analytical Equipment
Heritage Global Partners is preparing to auction a substantial selection of surplus life science research and development equipment from Capsida Biotherapeutics in Thousand Oaks, California.
Opening for bidding on 14 September 2026 at 7:00 PDT and closing from 9:00 PDT on 15 September, the online auction brings together equipment covering chromatography, laboratory automation, mass spectrometry, sequencing, bioreactor applications and analytical testing.
The sale presents an opportunity for laboratories, research organisations, biotechnology companies and equipment dealers looking to acquire established laboratory technology from leading manufacturers including Agilent, Hamilton, Repligen, Sartorius, Bruker, Illumina, Beckman Coulter and Thermo Scientific.
Chromatography Systems, Laboratory Automation and Mass Spectrometry Available
Among the key assets included in the auction are:
- Repligen KRM 20 chromatography system
- ÄKTA Pilot chromatography system
- ÄKTA Avant 150 chromatography system
- ÄKTA Avant 25 chromatography system
- Bruker MALDI Biotyper Sirius One mass spectrometer
- Three Hamilton Vantage liquid handling systems
- Two Hamilton Microlab NIMBUS liquid handling systems
- Two SCIEX PA 800 Plus biologics analysis systems
- Sartorius BIOSTAT bioreactor system
- Five Agilent 1260/1290 HPLC systems
- Agilent 4200 TapeStation
- Agilent Cary 60 UV-Vis spectrophotometer system
- Illumina NextSeq 2000 sequencing system
- Unchained Labs Big Tuna system
- Unchained Labs Lunatic system
- ZEISS Axioscan 7 slide scanner
- Beckman Coulter Vi-CELL BLU cell viability analyser
- Thermo Scientific CellInsight CX5 platform
- Three Applied Biosystems QuantStudio 7 Pro systems
- Eight INTEGRA ASSIST PLUS pipetting stations
The range of equipment available makes the auction particularly relevant to organisations expanding existing laboratory capabilities or establishing new research facilities. With multiple liquid handling, chromatography and analytical systems included, buyers can target individual instruments or potentially source equipment across several areas of their laboratory operation from a single sale.
The Capsida Biotherapeutics Life Science R&D Equipment Surplus auction opens on 14 September, with lots beginning to close on 15 September 2026.
About Heritage Global Partners
Heritage Global Partners is an international asset advisory and auction services company specialising in the sale of industrial, commercial and laboratory assets. The company conducts auctions and asset disposition projects across a broad range of sectors, including life sciences, pharmaceutical manufacturing, technology and industrial production, connecting surplus equipment with buyers around the world.
For more information, please visit: